|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 15709324.6 (espacenet) (Federated) (European Patent Register), 20150306 | | Patent/reg. no. and date | DK/EP 3113778, 20180606 | | Publication date | 20170111 | | Priority no. and date | GB 201403944, 20140306 | | EP pub. no. and date |
EP 3113778 20170111 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1 Doshomachi 4-chome Chuo-ku
Osaka-shi, Osaka 541-0045, JP | | Applicant ref. no. | WITH-UP1401EPDK | | Inventor | ALMOND, Sarah, c/o Takeda Cambridge Limited
418 Cambridge Science Park
Cambridge CB4 0PZ, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/501 (2006.01) , A61P 25/00 (2006.01) , A61P 25/14 (2006.01) | | Title | PYRIDAZINONDERIVATER TIL ANVENDELSE VED FOREBYGGELSE ELLER BEHANDLING AF EN ATAKSISK LIDELSE | | Int. application no. | GB2015050654 | | Int. publication no. | WO2015132608 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
